Miles, M.A.; Luong, R.; To, E.E.; Erlich, J.R.; Liong, S.; Liong, F.; Logan, J.M.; O’Leary, J.; Brooks, D.A.; Selemidis, S.
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells 2024, 13, 97.
https://doi.org/10.3390/cells13010097
AMA Style
Miles MA, Luong R, To EE, Erlich JR, Liong S, Liong F, Logan JM, O’Leary J, Brooks DA, Selemidis S.
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells. 2024; 13(1):97.
https://doi.org/10.3390/cells13010097
Chicago/Turabian Style
Miles, Mark A., Raymond Luong, Eunice E. To, Jonathan R. Erlich, Stella Liong, Felicia Liong, Jessica M. Logan, John O’Leary, Doug A. Brooks, and Stavros Selemidis.
2024. "TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development" Cells 13, no. 1: 97.
https://doi.org/10.3390/cells13010097
APA Style
Miles, M. A., Luong, R., To, E. E., Erlich, J. R., Liong, S., Liong, F., Logan, J. M., O’Leary, J., Brooks, D. A., & Selemidis, S.
(2024). TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells, 13(1), 97.
https://doi.org/10.3390/cells13010097